Stig Agurell

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

Annika Ohlsson, J.‐E. Lindgren, A. Wahlén et al. · Clinical Pharmacology & Therapeutics · 1980 · 474 citations

Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults

M. Ehrnebo, Stig Agurell, Birgitta Jalling et al. · European Journal of Clinical Pharmacology · 1971 · 265 citations

Biochemistry, Medicine, Age Differences +6

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration

Agneta Ohlsson, Jan‐Erik Lindgren, Susanne Andersson et al. · Journal of Mass Spectrometry · 1986 · 226 citations

Do Plasma Concentrations of Δ⁹‐Tetrahydrocannabinol Reflect the Degree of Intoxication?

Leo E. Hollister, H. K. Gillespie, Annika Ohlsson et al. · The Journal of Clinical Pharmacology · 1981 · 161 citations

Substance Use, Peak Concentration, Pharmacotherapy +21

Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis

Jan‐Erik Lindgren, Agneta Ohlsson, Stig Agurell et al. · Psychopharmacology · 1981 · 152 citations

Cannabis Use, Substance Abuse, Light Users +9